Prognostic value ofKRASandBRAFmutations in curatively resected colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value ofKRASandBRAFmutations in curatively resected colorectal cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 4, Pages 1275
Publisher
Baishideng Publishing Group Inc.
Online
2015-01-28
DOI
10.3748/wjg.v21.i4.1275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathological characteristics and prognostic impact of colorectal cancers with NRAS mutations
- (2014) TOSHIRO OGURA et al. ONCOLOGY REPORTS
- BRAFmutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis
- (2013) C. Clancy et al. Colorectal Disease
- KRAS Mutational Status in Japanese Patients with Colorectal Cancer: Results from a Nationwide, Multicenter, Cross-sectional Study
- (2013) Toshiaki Watanabe et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
- (2012) Ryota Nakanishi et al. International Journal of Clinical Oncology
- Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
- (2012) Daniel J. Sargent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
- (2012) Gholamreza Safaee Ardekani et al. PLoS One
- Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803
- (2011) S. Ogino et al. CLINICAL CANCER RESEARCH
- Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
- (2011) Jyh-Ming Liou et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
- (2011) F. A. Sinicrope et al. JNCI-Journal of the National Cancer Institute
- The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
- (2010) A. Fariña-Sarasqueta et al. ANNALS OF ONCOLOGY
- Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B
- (2009) S.-i. Asaka et al. CARCINOGENESIS
- Three DNA Methylation Epigenotypes in Human Colorectal Cancer
- (2009) K. Yagi et al. CLINICAL CANCER RESEARCH
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer
- (2008) A. J. French et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started